{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T10:35:57Z","timestamp":1789122957461,"version":"build-2803163510"},"reference-count":40,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejso.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Surgical Oncology"],"published-print":{"date-parts":[[2022,2]]},"DOI":"10.1016\/j.ejso.2021.09.002","type":"journal-article","created":{"date-parts":[[2021,9,8]],"date-time":"2021-09-08T18:09:43Z","timestamp":1631124583000},"page":"425-434","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"title":["Adjuvant radiotherapy improves long-term survival after resection for gallbladder cancer A population-based cohort study"],"prefix":"10.1016","volume":"48","author":[{"given":"Sivesh K.","family":"Kamarajah","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wasfi","family":"Al-Rawashdeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven A.","family":"White","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammed","family":"Abu Hilal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George I.","family":"Salti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fadi S.","family":"Dahdaleh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejso.2021.09.002_bib1","first-page":"99","article-title":"Gallbladder cancer: epidemiology and outcome","volume":"6","author":"Hundal","year":"2014","journal-title":"Clin Epidemiol"},{"issue":"8","key":"10.1016\/j.ejso.2021.09.002_bib2","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1002\/cncr.10831","article-title":"Is postoperative adjuvant chemotherapy useful for gallbladder carcinoma? A phase III multicenter prospective randomized controlled trial in patients with resected pancreaticobiliary carcinoma","volume":"95","author":"Takada","year":"2002","journal-title":"Cancer"},{"issue":"1","key":"10.1016\/j.ejso.2021.09.002_bib3","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1097\/01.sla.0000150166.94732.88","article-title":"Actual long-term outcome of extrahepatic bile duct cancer after surgical resection","volume":"241","author":"Jang","year":"2005","journal-title":"Ann Surg"},{"issue":"2","key":"10.1016\/j.ejso.2021.09.002_bib4","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1007\/s005340170039","article-title":"Recurrence after surgical resection of intrahepatic cholangiocarcinoma","volume":"8","author":"Yamamoto","year":"2001","journal-title":"J\u00a0Hepatobiliary Pancreat Surg"},{"issue":"5","key":"10.1016\/j.ejso.2021.09.002_bib5","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/S1470-2045(18)30915-X","article-title":"Capecitabine compared with observation in resected biliary tract cancer (BILCAP): a randomised, controlled, multicentre, phase 3 study","volume":"20","author":"Primrose","year":"2019","journal-title":"Lancet Oncol"},{"issue":"5","key":"10.1016\/j.ejso.2021.09.002_bib6","doi-asserted-by":"crossref","first-page":"563","DOI":"10.6004\/jnccn.2017.0059","article-title":"NCCN guidelines insights: hepatobiliary cancers, version 1.2017","volume":"15","author":"Benson","year":"2017","journal-title":"J\u00a0Natl Compr Canc Netw"},{"issue":"4","key":"10.1016\/j.ejso.2021.09.002_bib7","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1002\/jso.2930550408","article-title":"Multidisciplinary treatment of biliary tract cancers","volume":"55","author":"Kraybill","year":"1994","journal-title":"J\u00a0Surg Oncol"},{"issue":"1","key":"10.1016\/j.ejso.2021.09.002_bib8","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.ijrobp.2008.10.052","article-title":"Adjuvant therapy for gallbladder carcinoma: the mayo clinic experience","volume":"75","author":"Gold","year":"2009","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"1","key":"10.1016\/j.ejso.2021.09.002_bib9","doi-asserted-by":"crossref","first-page":"11770","DOI":"10.1038\/s41598-019-48099-z","article-title":"Benefit of adjuvant chemoradiotherapy in resected gallbladder carcinoma","volume":"9","author":"Kim","year":"2019","journal-title":"Sci Rep"},{"issue":"24","key":"10.1016\/j.ejso.2021.09.002_bib10","doi-asserted-by":"crossref","first-page":"2617","DOI":"10.1200\/JCO.2014.60.2219","article-title":"Swog S0809: a phase II intergroup trial of adjuvant capecitabine and gemcitabine followed by radiotherapy and concurrent capecitabine in extrahepatic cholangiocarcinoma and gallbladder carcinoma","volume":"33","author":"Ben-Josef","year":"2015","journal-title":"J\u00a0Clin Oncol"},{"issue":"2","key":"10.1016\/j.ejso.2021.09.002_bib11","doi-asserted-by":"crossref","DOI":"10.1093\/jnci\/djw202","article-title":"Adjuvant therapy for resected gallbladder cancer: analysis of the national cancer data Base","volume":"109","author":"Mantripragada","year":"2017","journal-title":"J\u00a0Natl Cancer Inst"},{"issue":"3","key":"10.1016\/j.ejso.2021.09.002_bib12","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1002\/bjs.10776","article-title":"Randomized clinical trial of adjuvant gemcitabine chemotherapy versus observation in resected bile duct cancer","volume":"105","author":"Ebata","year":"2018","journal-title":"Br J Surg"},{"issue":"6","key":"10.1016\/j.ejso.2021.09.002_bib13","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1097\/SLA.0b013e318190c53e","article-title":"Adjuvant intra-arterial chemotherapy and radiotherapy versus surgery alone in resectable pancreatic and periampullary cancer","volume":"248","author":"Morak","year":"2008","journal-title":"Ann Surg"},{"issue":"6","key":"10.1016\/j.ejso.2021.09.002_bib14","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1097\/00000658-199912000-00006","article-title":"Adjuvant radiotherapy and 5-fluorouracil after curative resection of cancer of the pancreas and periampullary region: phase III trial of the EORTC gastrointestinal tract cancer cooperative group","volume":"230","author":"Klinkenbijl","year":"1999","journal-title":"Ann Surg"},{"issue":"2","key":"10.1016\/j.ejso.2021.09.002_bib15","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1001\/jama.2012.7352","article-title":"Effect of adjuvant chemotherapy with fluorouracil plus folinic acid or gemcitabine vs observation on survival in patients with resected periampullary adenocarcinoma: the ESPAC-3 periampullary cancer randomized trial","volume":"308","author":"Neoptolemos","year":"2012","journal-title":"J\u00a0Am Med Assoc"},{"issue":"5","key":"10.1016\/j.ejso.2021.09.002_bib16","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1097\/SLA.0b013e318156eef3","article-title":"Long-term survival and metastatic pattern of pancreatic and periampullary cancer after adjuvant chemoradiation or observation: long-term results of EORTC trial 40891","volume":"246","author":"Smeenk","year":"2007","journal-title":"Ann Surg"},{"issue":"12","key":"10.1016\/j.ejso.2021.09.002_bib17","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1056\/NEJMoa032295","article-title":"A\u00a0randomized trial of chemoradiotherapy and chemotherapy after resection of pancreatic cancer","volume":"350","author":"Neoptolemos","year":"2004","journal-title":"N\u00a0Engl J Med"},{"issue":"16","key":"10.1016\/j.ejso.2021.09.002_bib18","doi-asserted-by":"crossref","first-page":"1934","DOI":"10.1200\/JCO.2011.40.5381","article-title":"Adjuvant therapy in the treatment of biliary tract cancer: a systematic review and meta-analysis","volume":"30","author":"Horgan","year":"2012","journal-title":"J\u00a0Clin Oncol"},{"issue":"9","key":"10.1016\/j.ejso.2021.09.002_bib19","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1016\/j.hpb.2017.05.010","article-title":"Adjuvant chemotherapy for resected biliary tract cancers: a systematic review and meta-analysis","volume":"19","author":"Ghidini","year":"2017","journal-title":"HPB"},{"issue":"4 Pt A","key":"10.1016\/j.ejso.2021.09.002_bib20","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1016\/j.ejso.2019.11.499","article-title":"Systemic adjuvant chemotherapy for cholangiocarcinoma surgery: a systematic review and meta-analysis","volume":"46","author":"Rangarajan","year":"2020","journal-title":"Eur J Surg Oncol"},{"issue":"4","key":"10.1016\/j.ejso.2021.09.002_bib21","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1002\/cncr.22852","article-title":"Validation of the 6th edition AJCC pancreatic cancer staging system: report from the national cancer Database","volume":"110","author":"Bilimoria","year":"2007","journal-title":"Cancer"},{"key":"10.1016\/j.ejso.2021.09.002_bib22","doi-asserted-by":"crossref","DOI":"10.1001\/jamasurg.2018.0492","article-title":"Practical guide to surgical data sets: national cancer Database (NCDB)","author":"Merkow","year":"2018","journal-title":"JAMA Surg"},{"issue":"23","key":"10.1016\/j.ejso.2021.09.002_bib23","doi-asserted-by":"crossref","first-page":"2963","DOI":"10.1200\/JCO.2013.49.5283","article-title":"Challenges of guarantee-time bias","volume":"31","author":"Giobbie-Hurder","year":"2013","journal-title":"J\u00a0Clin Oncol"},{"issue":"1","key":"10.1016\/j.ejso.2021.09.002_bib24","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1177\/0962280212445945","article-title":"A\u00a0comparison of two methods of estimating propensity scores after multiple imputation","volume":"25","author":"Mitra","year":"2016","journal-title":"Stat Methods Med Res"},{"issue":"7","key":"10.1016\/j.ejso.2021.09.002_bib25","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1002\/sim.5984","article-title":"The use of propensity score methods with survival or time-to-event outcomes: reporting measures of effect similar to those used in randomized experiments","volume":"33","author":"Austin","year":"2014","journal-title":"Stat Med"},{"key":"10.1016\/j.ejso.2021.09.002_bib26","article-title":"Association of adjuvant radiotherapy with survival after margin-negative resection of pancreatic ductal adenocarcinoma: a propensity-matched national cancer Database (NCDB) analysis","author":"Kamarajah","year":"2019","journal-title":"Ann Surg"},{"key":"10.1016\/j.ejso.2021.09.002_bib27","article-title":"Definitive chemoradiotherapy compared to neoadjuvant chemoradiotherapy with esophagectomy for locoregional esophageal cancer: national population-based cohort study","author":"Kamarajah","year":"2020","journal-title":"Ann Surg"},{"issue":"4","key":"10.1016\/j.ejso.2021.09.002_bib28","doi-asserted-by":"crossref","first-page":"302","DOI":"10.6004\/jnccn.2019.0019","article-title":"Guidelines insights: hepatobiliary cancers, version 2.2019","volume":"17","author":"Benson","year":"2019","journal-title":"J\u00a0Natl Compr Canc Netw"},{"issue":"33","key":"10.1016\/j.ejso.2021.09.002_bib29","doi-asserted-by":"crossref","first-page":"4173","DOI":"10.1200\/JCO.2012.44.1634","article-title":"Poor evidence to standardize adjuvant treatment for patients with biliary tract cancer","volume":"30","author":"Bariani","year":"2012","journal-title":"J\u00a0Clin Oncol"},{"issue":"34","key":"10.1016\/j.ejso.2021.09.002_bib30","doi-asserted-by":"crossref","first-page":"4215","DOI":"10.1200\/JCO.2012.41.6701","article-title":"Comparative effectiveness research in oncology methodology: observational data","volume":"30","author":"Hershman","year":"2012","journal-title":"J\u00a0Clin Oncol"},{"issue":"5","key":"10.1016\/j.ejso.2021.09.002_bib31","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1007\/s11605-007-0387-5","article-title":"Portal vein resection in surgery for cancer of biliary tract and pancreas: special reference to the relationship between the surgical outcome and site of primary tumor","volume":"12","author":"Kurosaki","year":"2008","journal-title":"J\u00a0Gastrointest Surg"},{"issue":"8","key":"10.1016\/j.ejso.2021.09.002_bib32","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1002\/cncr.11699","article-title":"Patterns of initial disease recurrence after resection of gallbladder carcinoma and hilar cholangiocarcinoma: implications for adjuvant therapeutic strategies","volume":"98","author":"Jarnagin","year":"2003","journal-title":"Cancer"},{"issue":"11","key":"10.1016\/j.ejso.2021.09.002_bib33","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1016\/j.hpb.2016.05.016","article-title":"Rates and patterns of recurrence after curative intent resection for gallbladder cancer: a multi-institution analysis from the US Extra-hepatic Biliary Malignancy Consortium","volume":"18","author":"Margonis","year":"2016","journal-title":"HPB"},{"issue":"5","key":"10.1016\/j.ejso.2021.09.002_bib34","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1007\/s11605-007-0109-z","article-title":"Actual recurrence patterns and risk factors influencing recurrence after curative resection with stage II gallbladder carcinoma","volume":"11","author":"Park","year":"2007","journal-title":"J\u00a0Gastrointest Surg"},{"issue":"4","key":"10.1016\/j.ejso.2021.09.002_bib35","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1007\/s11605-009-1140-z","article-title":"Risk factors influencing recurrence, patterns of recurrence, and the efficacy of adjuvant therapy after radical resection for gallbladder carcinoma","volume":"14","author":"Kim","year":"2010","journal-title":"J\u00a0Gastrointest Surg"},{"key":"10.1016\/j.ejso.2021.09.002_bib36","article-title":"Histopathologic predictors of survival and recurrence in resected ampullary adenocarcinoma: International multicenter cohort study","author":"Moekotte","year":"2019","journal-title":"Ann Surg"},{"issue":"7","key":"10.1016\/j.ejso.2021.09.002_bib37","doi-asserted-by":"crossref","DOI":"10.1093\/jnci\/djw324","article-title":"Limited use of adjuvant therapy in patients with resected gallbladder cancer despite a strong association with survival","volume":"109","author":"Mitin","year":"2017","journal-title":"J\u00a0Natl Cancer Inst"},{"key":"10.1016\/j.ejso.2021.09.002_bib38","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.ijsu.2018.02.052","article-title":"Adjuvant systemic therapy after resection of node positive gallbladder cancer: time for a well-designed trial? (Results of a US-national retrospective cohort study)","volume":"52","author":"Bergquist","year":"2018","journal-title":"Int J Surg"},{"issue":"9","key":"10.1016\/j.ejso.2021.09.002_bib39","doi-asserted-by":"crossref","first-page":"2998","DOI":"10.1245\/s10434-016-5262-8","article-title":"Impact of chemotherapy and external-beam radiation therapy on outcomes among patients with resected gallbladder cancer: a multi-institutional analysis","volume":"23","author":"Kim","year":"2016","journal-title":"Ann Surg Oncol"},{"issue":"9","key":"10.1016\/j.ejso.2021.09.002_bib40","doi-asserted-by":"crossref","first-page":"1666","DOI":"10.1007\/s11605-012-1935-1","article-title":"Neither neoadjuvant nor adjuvant therapy increases survival after biliary tract cancer resection with wide negative margins","volume":"16","author":"Glazer","year":"2012","journal-title":"J\u00a0Gastrointest Surg"}],"container-title":["European Journal of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0748798321007241?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0748798321007241?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T01:42:26Z","timestamp":1760060546000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0748798321007241"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2]]},"references-count":40,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2022,2]]}},"alternative-id":["S0748798321007241"],"URL":"https:\/\/doi.org\/10.1016\/j.ejso.2021.09.002","relation":{},"ISSN":["0748-7983"],"issn-type":[{"value":"0748-7983","type":"print"}],"subject":[],"published":{"date-parts":[[2022,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Adjuvant radiotherapy improves long-term survival after resection for gallbladder cancer A population-based cohort study","name":"articletitle","label":"Article Title"},{"value":"European Journal of Surgical Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejso.2021.09.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Ltd, BASO ~ The Association for Cancer Surgery, and the European Society of Surgical Oncology. All rights reserved.","name":"copyright","label":"Copyright"}]}}